Federal health officials last fall touted a new treatment for autism: leucovorin, a derivative of Vitamin B9 commonly used during cancer treatment. But the drugmaker, GSK, this week asked the Food and Drug Administration to pull its application.[#item_full_content]
Akron Fuels Possible Sign of Rust Belt Revival
For decades, the abandoned B.F. Goodrich tire factory stood as a reminder of the industrial collapse that hollowed out much of northeast Ohio. Now, the